Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup AnalysisCancer Discov 2022 Oct 18;[EPub Ahead of Print], G Jerusalem, YH Park, SA Hurvitz, S Modi, F Andre, IE Krop, X Gonzalez-Farre, B You, C Saura, SB Kim, CR Osborne, RK Murthy, L Gianni, T Takano, Y Liu, J Cathcart, C Lee, C Perrin
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.